glp-1 agonists blindness risk A new study analyzing U.S. insurance claims data found that people with #Type2Diabetes who started receptor had a modestly higher rate of ischemic optic neuropathy (ION), a condition causing sudden Ozempic Blindness Lawsuit [2026 Update]
Pay in 4 interest-free payments of $5.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
![glp-1 agonists blindness risk A new study analyzing U.S. insurance claims data found that people with #Type2Diabetes who started receptor had a modestly higher rate of ischemic optic neuropathy (ION), a condition causing sudden Ozempic Blindness Lawsuit [2026 Update]](https://www.robertkinglawfirm.com/wp-content/uploads/2024/07/ozempic-blurry-vision.webp)
![glp-1 agonists blindness risk A new study analyzing U.S. insurance claims data found that people with #Type2Diabetes who started receptor had a modestly higher rate of ischemic optic neuropathy (ION), a condition causing sudden Ozempic Blindness Lawsuit [2026 Update]](https://images.ctfassets.net/4f3rgqwzdznj/2t6DftuWUI0KuIk9hCJl2H/cf33971309e12f70cee6c63ecbd46b99/Diabetic_retinopathy_GoodRx.png)
![glp-1 agonists blindness risk A new study analyzing U.S. insurance claims data found that people with #Type2Diabetes who started receptor had a modestly higher rate of ischemic optic neuropathy (ION), a condition causing sudden Ozempic Blindness Lawsuit [2026 Update]](https://www.neurology.org/cms/10.1212/WNL.0000000000214864/asset/3468cf71-2e0c-4413-a0bf-aa653898ff28/assets/images/large/wnl.0000000000214864f5.jpg)
![glp-1 agonists blindness risk A new study analyzing U.S. insurance claims data found that people with #Type2Diabetes who started receptor had a modestly higher rate of ischemic optic neuropathy (ION), a condition causing sudden Ozempic Blindness Lawsuit [2026 Update]](https://res.cloudinary.com/broadcastmed/image/fetch/q_auto,f_auto,dpr_auto/https://www.glaucomaphysician.net/media/30hgcds4/pg15_fig1_sept25.jpg)
![glp-1 agonists blindness risk A new study analyzing U.S. insurance claims data found that people with #Type2Diabetes who started receptor had a modestly higher rate of ischemic optic neuropathy (ION), a condition causing sudden Ozempic Blindness Lawsuit [2026 Update]](https://www.aaojournal.org/cms/asset/b109b8db-f38c-4236-a209-0e95dcbe9091/gr2.jpg)
















